Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants:ex vivo, in situandin vivostudies
- 5 June 2013
- journal article
- Published by Taylor & Francis Ltd in Drug Development and Industrial Pharmacy
- Vol. 40 (8), 1030-1043
- https://doi.org/10.3109/03639045.2013.801984
Abstract
The aim of the present study was to improve the dissolution, permeability and therefore oral bioavailability of the fexofenadine hydrochloride (FEX), by preparing lipid surfactant based dispersions using self-emulsifying carriers, i.e. Gelucire 44/14 (GLC) and d-α-tocopheryl polyethylene glycol 1000 succinate (Vitamin E TPGS or TPGS). The reprecipitation studies were conducted using these carriers to evaluate inhibition of reprecipitation by maintaining super saturation state. The aqueous solubility of the FEX was increased linearly with increasing GLC, TPGS concentrations as verified by the phase solubility studies. The dispersions of FEX were prepared in different drug/GLC (GD) and drug/TPGS (TD) ratios by melt method and evaluated. The prepared dispersions showed improved dissolution rate in distilled water as dissolution media and highest dissolution rate was achieved with dispersions prepared using TPGS. The solid state characterization was carried by differential scanning calorimetry and scanning electron microscopy indicated reduced crystallinity of the drug. Fourier transform infrared spectroscopy revealed the compatibility of drug with carriers. The ex vivo permeation studies conducted using intestinal gut sac technique, resulted in reduced efflux of the drug by inhibiting intestinal P-glycoprotein from the dispersions. The in situ perfusion studies and in vivo pharmacokinetic studies in male wistar rats showed improved absorption and oral bioavailability from the prepared dispersions as compared to pure drug.Keywords
This publication has 30 references indexed in Scilit:
- Preparation and evaluation of fexofenadine microemulsions for intranasal deliveryInternational Journal of Pharmaceutics, 2010
- Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studiesInternational Journal of Pharmaceutics, 2006
- Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeabilityJournal of Pharmaceutical Sciences, 2005
- Interest of Multifunctional Lipid Excipients: Case of Gelucire® 44/14Drug Development and Industrial Pharmacy, 2005
- Modulation of Intestinal P-Glycoprotein Function by Cremophor EL and Other Surfactants by an In Vitro Diffusion Chamber Method Using the Isolated Rat Intestinal MembranesJournal of Pharmaceutical Sciences, 2004
- Development and Evaluation of Glyburide Fast Dissolving Tablets Using Solid Dispersion TechniqueDrug Development and Industrial Pharmacy, 2004
- An in vitro examination of the impact of polyethylene glycol 400, pluronic P85, and vitamin E d-a-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestineAAPS PharmSci, 2002
- Dose‐dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor ELBritish Journal of Clinical Pharmacology, 2002
- Oral absorption of anti-aids nucleoside analogues. 1. Intestinal transport of didanosine in rat and rabbit preparationsJournal of Pharmaceutical Sciences, 1995
- The concept of dissolution efficiencyJournal of Pharmacy and Pharmacology, 1975